ESMO Open

  2059-7029

 

  Anh Quốc

Cơ quản chủ quản:  Elsevier BV , Elsevier

Lĩnh vực:
OncologyCancer Research

Phân tích ảnh hưởng

Thông tin về tạp chí

 

he journal aims to publish research in all disciplines, experimental, translational, diagnostic and therapeutic areas related to oncology, including: original articles, reviews, editorials and correspondence. In addition the journal welcomes phase I trials and meta-analyses, and will also publish reviews from important European Society for Medical Oncology (ESMO) conferences and meetings as well as position statements on behalf of ESMO. ESMO Open aims to operate a fast submission process with continuous publication online, to ensure that timely, up-to-date research is available worldwide and adheres to a rigorous and transparent peer review process. ESMO Open adheres to the highest possible industry standards concerning publication ethics With the widest possible reach and an international editorial board of experts and key opinion leaders, the journal aims to rapidly disseminate the best in innovative clinical and translational cancer research and improve the quality of education, prevention, diagnosis, treatment and patient care worldwide.

Các bài báo tiêu biểu

Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers
Tập 1 - Trang e000142 - 2016
Josep Tabernero, Malvika Vyas, Rosa Giuliani, Dirk Arnold, Fatima Cardoso, Paolo G. Casali, Andres Cervantes, Alexander M.M. Eggermont, Alexandru Eniu, Jacek Jassem, George Pentheroudakis, Solange Peters, Stefan Rauh, Christoph C. Zielinski, Rolf A. Stahel, Emile Voest, Jean-Yves Douillard, Keith McGregor, Fortunato Ciardiello
PO-081 Notch signalling pathway plays a crucial role in maintaining the cancer stem cell population in lung and colorectal cancer
Tập 3 - Trang A52-A53 - 2018
M. Novikova, N. Khromova, V. Rybko, V. Dugina, B. Kopnin, P. Kopnin
The current role of precision surgery in oligometastatic prostate cancer
Tập 7 - Trang 100597 - 2022
M. von Deimling, P. Rajwa, D. Tilki, A. Heidenreich, M. Pallauf, A. Bianchi, T. Yanagisawa, T. Kawada, P.I. Karakiewicz, P. Gontero, B. Pradere, G. Ploussard, M. Rink, S.F. Shariat
PO-084 Familial risk of colorectal cancer in half-siblings similar to that in siblings
Tập 3 - Trang A259 - 2018
Y. Tian, E. Kharazmi, K. Sundquist, J. Sundquist, M. Fallah
PO-094 Persistent Myc activity prevents resolution of liver injury
Tập 3 - Trang A57-A58 - 2018
L. Pellegrinet, A. Laing, F. Kyle, T. Littlewood, A. Hayday, G. Evan
PO-494 Using functional genetic screens to understand resistance to PARPi in BRCA-deficient tumours
Tập 3 - Trang A215-A216 - 2018
M. Dias, E. Gogola, J. Bhin, F. Rolfs, S. Rottenberg, J. Jonkers
Emerging targets for cancer treatment: S100A9/RAGE
Tập 8 - Trang 100751 - 2023
M. Valiente, J.M. Sepúlveda, A. Pérez
PO-424 modulating hexokinase 2 (HK2) as a novel approach to target metabolic immuno-oncology
Tập 3 - Trang A396-A397 - 2018
V. Behar, R. Yosef, E. Dor-On, N. Amsalem, Y. Horev, O.M. Becker
Recent advances in adjuvant therapy for patients with melanoma
Tập 3 - Trang e000337 - 2018
Jeffrey Weber
PO-469 Role of promoter hypermethylation of hocT1 gene (SLC22A1) in response to imatinib of chronic myeloid leukaemia patients
Tập 3 - Trang A206 - 2018
N. Bhutani, S.A. Guru, P. Yadav, K. Rabari, A. Saxena